Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/22696
Full metadata record
DC FieldValueLanguage
dc.contributor.authorParker, Renee-
dc.contributor.authorEisenach, James C.-
dc.contributor.authorVincler, Michelle-
dc.date.accessioned2021-11-17T12:57:45Z-
dc.date.available2021-11-17T12:57:45Z-
dc.date.issued2009-05-
dc.identifier.citationGürün, M. S. vd. (2009). "The effect of peripherally administered cdp-choline in an acute inflammatory pain model: The role of α7 nicotinic acetylcholine receptor". Anesthesia and Analgesia, 108(5), 1680-1687.en_US
dc.identifier.issn0003-2999-
dc.identifier.urihttps://doi.org/10.1213/ane.0b013e31819dcd08-
dc.identifier.urihttps://journals.lww.com/anesthesia-analgesia/Fulltext/2009/05000/The_Effect_of_Peripherally_Administered.51.aspx-
dc.identifier.urihttp://hdl.handle.net/11452/22696-
dc.description.abstractBACKGROUND: CDP-choline (citicholine; cytidine-5'-diphosphate choline) is an endogenously produced nucleotide which, when injected intracerebroventricularly, exerts an antinociceptive effect in acute pain models mediated by central cholinergic mechanisms and alpha 7 nicotinic acetylcholine receptors (alpha 7nAChR). Previous reports also suggest that the peripheral cholinergic system has an antiinflammatory role mediated by alpha 7nAChRs on macrophages. METHODS: We used male Sprague-Dawley rats to assess the antihypersensitivity and antiinflammatory effect of CDP-choline after intraplantar injection of carrageenan (100 mu L, 2%). Mechanical paw withdrawal thresholds and paw thickness were measured by Randall-Selitto testing and microcallipers, respectively. All drugs were administered intraplantarly in a volume 50 mu L. RESULTS: CDP-choline (1, 2.5, 5 mu mol; intraplantar) increased the mechanical paw withdrawal threshold and decreased paw edema in a dose- and time-dependent manner in the carrageenan-injected hindpaw. CDP-choline administration to the noninflamed contralateral hindpaw did not alter ipsdateral inflammation. Methyllycaconitine (100 nmol), a selective alpha 7nAChR antagonist, completely blocked the effects of CDP-choline when administered to the inflamed hindpaw. However, the administration of methyllycaconitine to the contralateral hindpaw did not block the effects of CDP-choline in the ipsilateral paw. The administration of CDP-choline (5 mu mol) 10 min after carrageenan administration to the ipsilateral hindpaw did not reduce swelling and edema but did significantly reduce hypersensitivity. Treatment with CDP-choline decreased tumor necrosis factor-a production in the rat paw tissue after carrageenan. CONCLUSIONS: The results of this study suggest that intraplantar CDP-choline has antihypersensitivity and antiinflammatory effects mediated via alpha 7nAChRs in the carrageenan-induced inflammatory pain model.en_US
dc.description.sponsorshipUnited States Department of Health & Human Services National Institutes of Health (NIH) - USA (NS048158)en_US
dc.description.sponsorshipUnited States Department of Health & Human Services National Institutes of Health (NIH) - USA (GM48085)en_US
dc.description.sponsorshipFulbright Commission Turkeyen_US
dc.description.sponsorshipUnited States Department of Health & Human Services National Institutes of Health (NIH) - USA NIH National Institute of General Medical Sciences (NIGMS) (R01GM048085)en_US
dc.description.sponsorshipUnited States Department of Health & Human Services National Institutes of Health (NIH) - USA NIH National Institute of General Medical Sciences (NIGMS) (R37GM048085)en_US
dc.language.isoenen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAnalgesic activityen_US
dc.subjectHyperalgesiaen_US
dc.subjectCiticolineen_US
dc.subjectResponsesen_US
dc.subjectNeuronsen_US
dc.subjectRatsen_US
dc.subjectSkinen_US
dc.subjectPawen_US
dc.subjectAnesthesiologyen_US
dc.subject.meshAconitineen_US
dc.subject.meshAnalgesicsen_US
dc.subject.meshAnimalsen_US
dc.subject.meshAnti-inflammatory agentsen_US
dc.subject.meshCarrageenanen_US
dc.subject.meshCytidine diphosphate cholineen_US
dc.subject.meshDisease models, animalen_US
dc.subject.meshDose-response relationship, drugen_US
dc.subject.meshEdemaen_US
dc.subject.meshInflammationen_US
dc.subject.meshInjectionsen_US
dc.subject.meshMaleen_US
dc.subject.meshNicotinic antagonistsen_US
dc.subject.meshPainen_US
dc.subject.meshPain measurementen_US
dc.subject.meshPain thresholden_US
dc.subject.meshRatsen_US
dc.subject.meshRats, sprague-dawleyen_US
dc.subject.meshReceptors, nicotinicen_US
dc.subject.meshTime factorsen_US
dc.subject.meshTumor necrosis factor-alphaen_US
dc.subject.meshNicotinic agonistsen_US
dc.titleThe effect of peripherally administered cdp-choline in an acute inflammatory pain model: The role of α7 nicotinic acetylcholine receptoren_US
dc.typeArticleen_US
dc.identifier.wos000265422300051tr_TR
dc.identifier.scopus2-s2.0-65349139499tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Farmakoloji ve Klinik Farmakoloji Anabilim Dalı.tr_TR
dc.identifier.startpage1680tr_TR
dc.identifier.endpage1687tr_TR
dc.identifier.volume108tr_TR
dc.identifier.issue5tr_TR
dc.relation.journalAnesthesia and Analgesiaen_US
dc.contributor.buuauthorGürün, Mine Sibel-
dc.contributor.researcheridAAG-8716-2019tr_TR
dc.relation.collaborationYurt dışıtr_TR
dc.identifier.pubmed19372354tr_TR
dc.subject.wosAnesthesiologyen_US
dc.indexed.wosSCIEen_US
dc.indexed.scopusScopusen_US
dc.indexed.pubmedPubmeden_US
dc.wos.quartileQ1en_US
dc.contributor.scopusid55664349700tr_TR
dc.subject.scopusCiticoline; Neuroprotective Agents; Glycerylphosphorylcholineen_US
dc.subject.emtreeAlpha 7 nicotinic acetylcholine receptoren_US
dc.subject.emtreeCarrageenanen_US
dc.subject.emtreeCholinergic receptoren_US
dc.subject.emtreeCiticolineen_US
dc.subject.emtreeSodium chlorideen_US
dc.subject.emtreeUnclassified drugen_US
dc.subject.emtreeAconitineen_US
dc.subject.emtreeAlpha-bungarotoxin receptoren_US
dc.subject.emtreeAnalgesic agenten_US
dc.subject.emtreeAntiinflammatory agenten_US
dc.subject.emtreeBungarotoxin receptoren_US
dc.subject.emtreeCiticolineen_US
dc.subject.emtreeDrug derivativeen_US
dc.subject.emtreeMethyllycaconitineen_US
dc.subject.emtreeNicotinic agenten_US
dc.subject.emtreeNicotinic receptoren_US
dc.subject.emtreeNicotinic receptor blocking agenten_US
dc.subject.emtreeTumor necrosis factor alphaen_US
dc.subject.emtreeAnimal experimenten_US
dc.subject.emtreeAnimal modelen_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeControlled studyen_US
dc.subject.emtreeDrug dose comparisonen_US
dc.subject.emtreeInflammationen_US
dc.subject.emtreeMacrophageen_US
dc.subject.emtreeMaleen_US
dc.subject.emtreeNonhumanen_US
dc.subject.emtreePainen_US
dc.subject.emtreePaw edemaen_US
dc.subject.emtreePriority journalen_US
dc.subject.emtreeRaten_US
dc.subject.emtreeAnimalen_US
dc.subject.emtreeChemically induced disorderen_US
dc.subject.emtreeDisease modelen_US
dc.subject.emtreeDose responseen_US
dc.subject.emtreeDrug effecten_US
dc.subject.emtreeEdemaen_US
dc.subject.emtreeInflammationen_US
dc.subject.emtreeInjectionen_US
dc.subject.emtreeMetabolismen_US
dc.subject.emtreePainen_US
dc.subject.emtreePain assessmenten_US
dc.subject.emtreePain thresholden_US
dc.subject.emtreeSprague Dawley raten_US
dc.subject.emtreeTimeen_US
Appears in Collections:Scopus
Web of Science

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.